Skip to main content
. 2013 Oct 9;168(4):3572–3579. doi: 10.1016/j.ijcard.2013.05.068

Fig. 5.

Fig. 5

Forest Plot of drug withdrawal (A) and serious adverse events (B) amongst RCTs of double-blind beta-blocker versus placebo controlled trials. Overall there are more withdrawals and serious adverse events amongst participants in the placebo groups.